Skip to Content

PharmaRoth Labs Inc ROTH

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ROTH is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$5.95
Uncertainty
Extreme
1-Star Price
$6.78
5-Star Price
Economic Moat
Zcls
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ROTH is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$149.35
Volume/Avg
20,000 / 45,525

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
2

Valuation

Metric
ROTH
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ROTH
Quick Ratio
0.24
Current Ratio
0.24
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
ROTH
Return on Assets (Normalized)
−1,310.11%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRXyjbn$541.4 Bil
VRTX
Vertex Pharmaceuticals IncKzbkbk$110.3 Bil
REGN
Regeneron Pharmaceuticals IncJbklmd$108.4 Bil
MRNA
Moderna IncTwk$37.2 Bil
ARGX
argenx SE ADRRmtp$23.7 Bil
BNTX
BioNTech SE ADRNmyn$21.7 Bil
ALNY
Alnylam Pharmaceuticals IncNhxff$19.5 Bil
BMRN
Biomarin Pharmaceutical IncNnrnsx$16.7 Bil
RPRX
Royalty Pharma PLC Class AJdvtmk$13.7 Bil
INCY
Incyte CorpBjbvlmv$13.5 Bil

Sponsor Center